New Bowel Cancer Drug Target Discovered

Exclusively targeting Wnt signalling in tumour cells reduces growth of tumours derived from colon cancer cells without the toxic effects on healthy cells.

Bowel cancer is a general term for cancer that begins in the large bowel. Depending on where the cancer starts, bowel cancer is sometimes called colon or rectal cancer. Researchers have discovered a new drug target for bowel cancer that is specific to tumour cells and therefore less toxic than conventional therapies.

"There has long been a need to find more effective and less toxic drugs to treat bowel cancer," says Laura Novellasdemunt, first author of the paper and researcher at the Francis Crick Institute. "We have found a novel drug target that could provide the basis for a better therapy in patients in the future."

Existing Illnesses may Delay Bowel Cancer Diagnosis
During cancer diagnosis, other diseases can be a distraction because they also require attention or can mask what would otherwise be flagged as a sign of cancer.

‘Bowel cancer can affect your daily life in different ways, depending on what stage it's at and the treatment you are having. How people cope with their diagnosis and treatment varies from person to person.’

Most bowel cancers are caused by a mutation in a gene called APC that in its healthy form acts to prevent cancer formation. Mutated APC genes cause excess activity of a cell signalling pathway called 'Wnt', which has been associated with bowel cancer for over 20 years.

Wnt signalling is vital for many organs, so drugs designed to block Wnt signalling in cancer cause very toxic side effects in other parts of the body. This has been a major hurdle in developing effective and safe bowel cancer therapies. The team at the Crick have found a way to exclusively target Wnt signalling in tumour cells, that reduces growth of tumours derived from colon cancer cells without the toxic effects on healthy cells. Their findings will be published in Cell Reports.

The team used the gene-editing tool CRISPR to cut the APC gene at various positions, and found a crucial part of the gene that causes dangerous levels of Wnt signalling and cancer formation.

Eating Omega-3 Rich Foods May Help Fight Bowel Cancer
Bowel cancer is the development of cancer from the colon or rectum. Foods that contain omega-3 rich fatty acids may help fight bowel cancer.

Using a number of molecular techniques, they identified a protein involved in over activation of the Wnt pathway in cancer. Preventing the activity of this protein by genetic deletion or blocking it with drugs caused a reduction in Wnt signalling in cancer cells and slowed down tumour growth in mice. Importantly, the drug was found to act exclusively on the tumour cells, and have no effect on Wnt signalling in healthy cells.

"Current treatment for bowel cancer is mostly generic, while targeted therapy will help future development of personalised medicine," says Vivian Li, senior author of the paper and Group Leader at the Francis Crick Institute. "The protein that we've identified holds great promise as a therapeutic target for bowel cancer treatment."

Predicting Bowel Cancer Survival Accurately
Bowel cancer means cancer that starts in the colon (large bowel) or back passage (rectum). It is also known as colorectal cancer.

The next step will be to see if deleting the gene that makes the protein in mice will prevent them from developing bowel cancer. This will provide further evidence that the protein is a viable anti-cancer drug target.

Source-Eurekalert

Low Complication Rates In Colonoscopy Screening For Bowel Cancer
Bowel cancer is the most common cancer. It also the 4th most common cause of death and the risk for developing complications is low during and after colonoscopy.